Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network

Published:2016-02-03 Issue:6 Volume:23 Page:447-454
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Younossi Z. M.¹,Bacon B. R.²,Dieterich D. T.³,Flamm S. L.⁴,Kowdley K.⁵,Milligan S.⁶,Tsai N.⁷,Nezam A.⁸

Affiliation:

1. Center for Liver Diseases; Department of Medicine; Inova Fairfax Hospital; Falls Church VA USA

2. Division of GI and Hepatology; Saint Louis University School of Medicine; St. Louis MO USA

3. Icahn School of Medicine; Mount Sinai; New York NY USA

4. Feinberg School of Medicine; Northwestern University; Chicago IL USA

5. Liver Care Network; Swedish Medical Center; Seattle WA USA

6. Trio Health Analytics; La Jolla CA USA

7. Queens Medical Center; University of Hawaii; Honolulu HI USA

8. Beth Israel Deaconess Medical Center; Boston MA USA

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12506/fullpdf

Reference12 articles.

1. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis;Kowdley;N Engl J Med,2014

2. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study;Lawitz;Lancet,2014

3. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection;Linas;Ann Intern Med,2015

4. Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens;Younossi;Hepatology,2014

5. The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C;Younossi;Dig Liver Dis,2014

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics associated with receipt of treatment among patients diagnosed with chronic hepatitis C virus;Journal of Viral Hepatitis;2023-06-28

2. Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study;Drug and Alcohol Dependence Reports;2023-06

3. How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States;International Journal of Drug Policy;2023-02

4. Healthcare resource utilization in Hepatitis C-infected patients completing eight versus twelve weeks of treatment: A retrospective cohort study;Frontiers in Gastroenterology;2022-09-15

5. Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured;American Journal of Preventive Medicine;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3